703 related articles for article (PubMed ID: 26336165)
1. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
2. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
Yamada S; Taniguchi M; Tokumoto M; Toyonaga J; Fujisaki K; Suehiro T; Noguchi H; Iida M; Tsuruya K; Kitazono T
J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H
Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775
[TBL] [Abstract][Full Text] [Related]
4. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.
McCabe KM; Booth SL; Fu X; Shobeiri N; Pang JJ; Adams MA; Holden RM
Kidney Int; 2013 May; 83(5):835-44. PubMed ID: 23344475
[TBL] [Abstract][Full Text] [Related]
5. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.
Yamada S; Tokumoto M; Tatsumoto N; Taniguchi M; Noguchi H; Nakano T; Masutani K; Ooboshi H; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1418-28. PubMed ID: 24808541
[TBL] [Abstract][Full Text] [Related]
6. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of spironolactone on vascular calcification in chronic kidney disease.
Hammer F; Buehling SS; Masyout J; Malzahn U; Hauser T; Auer T; Grebe S; Feger M; Tuffaha R; Degenhart G; Lang F; Pasch A; Alesutan I; Wanner C; Krane V; Voelkl J
Biochem Biophys Res Commun; 2021 Dec; 582():28-34. PubMed ID: 34678593
[TBL] [Abstract][Full Text] [Related]
9. High glucose concentration does not modulate the formation of arterial medial calcification in experimental uremic rats.
Yoshida T; Yamashita M; Horimai C; Hayashi M
J Vasc Res; 2013; 50(6):512-20. PubMed ID: 24216515
[TBL] [Abstract][Full Text] [Related]
10. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
11. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
De Schutter TM; Behets GJ; Geryl H; Peter ME; Steppan S; Gundlach K; Passlick-Deetjen J; D'Haese PC; Neven E
Kidney Int; 2013 Jun; 83(6):1109-17. PubMed ID: 23486515
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1.
Wang P; Quan Z; Luo D; Chen W; Peng D
Mol Med Rep; 2019 May; 19(5):3622-3632. PubMed ID: 30896801
[TBL] [Abstract][Full Text] [Related]
13. Impact of aldosterone on osteoinductive signaling and vascular calcification.
Lang F; Ritz E; Alesutan I; Voelkl J
Nephron Physiol; 2014; 128(1-2):40-5. PubMed ID: 25377380
[TBL] [Abstract][Full Text] [Related]
14. Circulating MicroRNA-125b Predicts the Presence and Progression of Uremic Vascular Calcification.
Chao CT; Liu YP; Su SF; Yeh HY; Chen HY; Lee PJ; Chen WJ; Lee YM; Huang JW; Chiang CK; Hung KY; Chen HW
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1402-1414. PubMed ID: 28522697
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
[TBL] [Abstract][Full Text] [Related]
16. Magnesium Modifies the Impact of Calcitriol Treatment on Vascular Calcification in Experimental Chronic Kidney Disease.
Zelt JG; McCabe KM; Svajger B; Barron H; Laverty K; Holden RM; Adams MA
J Pharmacol Exp Ther; 2015 Dec; 355(3):451-62. PubMed ID: 26487689
[TBL] [Abstract][Full Text] [Related]
17. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
[TBL] [Abstract][Full Text] [Related]
18. Magnesium Citrate Protects Against Vascular Calcification in an Adenine-induced Chronic Renal Failure Rat Model.
Yao Z; Xu Y; Ma W; Sun XY; Jia S; Zheng Y; Liu X; Fan Y; Wang C
J Cardiovasc Pharmacol; 2018 Dec; 72(6):270-276. PubMed ID: 29738375
[TBL] [Abstract][Full Text] [Related]
19. Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.
Han X; Wang LY; Diao ZL; Liu WH
Atherosclerosis; 2016 Jan; 244():1-8. PubMed ID: 26581047
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
